Ligand · BEV
BEV · N-[(2Z)-1,3-thiazolidin-2-ylidene]sulfamide
BEV, N-[(2Z)-1,3-thiazolidin-2-ylidene]sulfamide (C3 H7 N3 O2 S2, 181.2 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its residues within 4.5 Å, the residues it binds most and the…
- Component
- BEV
- Formula
- C3 H7 N3 O2 S2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
BEV in 2 structures; the first of them:
- 3M14 · Carbonic Anhydrase II in complex with novel sulfonamide inhibitor · BEV A505 · binds GLN92, HIS94, HIS96, GLU106, HIS119, VAL121, PHE131, SER197 and 4 more
- 3M14 · Carbonic anhydrase II in complex with novel sulfonamide inhibitor · BEV A505 · binds GLN92, HIS94, HIS96, GLU106, HIS119, VAL121, PHE131, SER197 and 4 more
Residues it binds most
HIS 2, THR 2, GLN 2, GLU 2, LEU 2, PHE 2, SER 2, TRP 2, VAL 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.